# Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions

> **NCT01132222** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 34 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ibuprofen + Pseudoephedrine Hydrochloride

## Key facts

- **NCT ID:** NCT01132222
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2010-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01132222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01132222, "Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01132222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*